FGP
Freestone Grove Partners Portfolio holdings
AUM
$15.6B
Turnover
60.27%
1-Year Est. Return
27.39%
This Fund
S&P 500
This Quarter
Est. Return
+0.81%
1 Year Est. Return
+27.39%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$14.2B
AUM Growth
+$326M
(+2.4%)
Cap. Flow
+$206M
Cap. Flow
% of AUM
1.46%
Top 10 Holdings %
Top 10 Hldgs %
19%
Holding
1,229
New
515
Increased
214
Reduced
228
Closed
267
Avg Time Held Equity + Options
0.3
years
Top 10 Avg Time Held Equity + Options
0.2
years
Top 20 Avg Time Held Equity + Options
0.1
years
Avg Time Held Equity only
0.3
years
Top 10 Avg Time Held Equity only
0.2
years
Top 20 Avg Time Held Equity only
0.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$134M |
| 2 |
Pinnacle Financial Partners Inc
PNFP
|
+$120M |
| 3 |
KKR & Co
KKR
|
+$113M |
| 4 |
Mondelez International
MDLZ
|
+$103M |
| 5 |
AXIS Capital
AXS
|
+$97.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$303M |
| 2 |
Boston Scientific
BSX
|
+$127M |
| 3 |
Lennar Class A
LEN
|
+$95.9M |
| 4 |
Martin Marietta Materials
MLM
|
+$94.6M |
| 5 |
Colgate-Palmolive
CL
|
+$92M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.98% |
| 2 | Technology | 14.39% |
| 3 | Miscellaneous | 12.72% |
| 4 | Industrials | 12.27% |
| 5 | Healthcare | 11.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
401
Neurocrine Biosciences
NBIX
$13.8B
| $1.58M | 0.01% |
11,997
-128,532
| -91% | -$17.1M |
2025 Q1
4 quarters
|
|
402
American Eagle Outfitters
AEO
$2.95B
| $1.57M | 0.01% |
+93,883
| New | +$2.11M |
2026 Q1
0 quarters
|
|
403
Newmont
NEM
$118B
| $1.55M | 0.01% |
14,345
+10,160
| +243% | +$1.17M |
2025 Q3
2 quarters
|
|
404
Tetra Tech
TTEK
$8.61B
| $1.55M | 0.01% |
+51,353
| New | +$1.82M |
2026 Q1
0 quarters
|
|
405
Genpact
G
$5.91B
| $1.51M | 0.01% |
+40,482
| New | +$1.67M |
2026 Q1
0 quarters
|
|
406
Copart
CPRT
$24.3B
| $1.5M | 0.01% |
45,182
-18,482
| -29% | -$694K |
2025 Q4
1 quarter
|
|
407
Churchill Downs
CHDN
$5.58B
| $1.5M | 0.01% |
+16,676
| New | +$1.58M |
2026 Q1
0 quarters
|
|
408
Verra Mobility
VRRM
$447M
| $1.49M | 0.01% |
104,485
+63,207
| +153% | +$1.16M |
2025 Q3
2 quarters
|
|
409
Ecolab
ECL
$80.7B
| $1.48M | 0.01% |
+5,565
| New | +$1.57M |
2026 Q1
0 quarters
|
|
410
Franklin Electric
FELE
$4.41B
| $1.47M | 0.01% |
15,945
+678
| +4% | +$66.5K |
2024 Q4
5 quarters
|
|
411
StandardAero Inc
SARO
$6.54B
| $1.47M | 0.01% |
56,725
-97,561
| -63% | -$2.91M |
2024 Q4
5 quarters
|
|
412
Reynolds Consumer Products
REYN
$4.75B
| $1.45M | 0.01% |
+68,538
| New | +$1.57M |
2026 Q1
0 quarters
|
|
413
Valmont Industries
VMI
$8.98B
| $1.45M | 0.01% |
3,619
+3,018
| +502% | +$1.32M |
2025 Q2
3 quarters
|
|
414
Rithm Capital
RITM
$4.66B
| $1.44M | 0.01% |
152,414
+112,878
| +286% | +$1.18M |
2025 Q2
3 quarters
|
|
415
Qualcomm
QCOM
$184B
| $1.44M | 0.01% |
+11,199
| New | +$1.63M |
2026 Q1
0 quarters
|
|
416
Radian Group
RDN
$4.42B
| $1.44M | 0.01% |
+43,416
| New | +$1.46M |
2026 Q1
0 quarters
|
|
417
Skyworks Solutions
SWKS
$18.1B
| $1.42M | 0.01% |
26,463
-261
| -1% | -$15.2K |
2025 Q4
1 quarter
|
|
418
H&R Block
HRB
$5.64B
| $1.4M | 0.01% |
43,978
+18,743
| +74% | +$653K |
2025 Q3
2 quarters
|
|
419
Wayfair
W
$14.4B
| $1.39M | 0.01% |
18,434
+2,765
| +18% | +$250K |
2025 Q4
1 quarter
|
|
420
Ryan Specialty Holdings
RYAN
$4.64B
| $1.38M | 0.01% |
+40,958
| New | +$1.75M |
2026 Q1
0 quarters
|
|
421
Adobe
ADBE
$93.7B
| $1.38M | 0.01% |
+5,675
| New | +$1.57M |
2026 Q1
0 quarters
|
|
422
Rayonier
RYN
$5.55B
| $1.38M | 0.01% |
66,779
+55,238
| +479% | +$1.22M |
2025 Q4
1 quarter
|
|
423
Owens Corning
OC
$8.79B
| $1.36M | 0.01% |
12,584
-421,435
| -97% | -$50.2M |
2025 Q4
1 quarter
|
|
424
Southwest Gas
SWX
$6.18B
| $1.35M | 0.01% |
+15,529
| New | +$1.32M |
2026 Q1
0 quarters
|
|
425
Halozyme
HALO
$13.3B
| $1.34M | 0.01% |
20,719
+5,183
| +33% | +$365K |
2025 Q4
1 quarter
|
|
Similar funds
ECM
MIFH
GF
AIM
OTPPB
AA
IWC
Freestone Grove Partners's Q1 2026 Portfolio in Review
As of Q1 2026, Freestone Grove Partners held 1,229 positions worth $14.2B, up 2.4% from $13.8B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Freestone Grove Partners's Q1 2026 filing shows 515 new, 214 increased, 228 reduced and 267 closed positions. Its largest new stake was Citigroup: 1,180,436 shares worth $134M. The largest sale was iShares Core S&P 500 ETF, an estimated $303M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 15% a quarter earlier, followed by Technology and Miscellaneous.
- Freestone Grove Partners's largest Q1 2026 buy was Citigroup: 1,180,436 shares worth $134M.
- Freestone Grove Partners added most to AXIS Capital in Q1 2026, an estimated $97.1M increase.
- Freestone Grove Partners's biggest Q1 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $303M.
- Freestone Grove Partners fully exited Boston Scientific in Q1 2026, selling an estimated $127M.
- Freestone Grove Partners's ten largest holdings make up 19% of its $14.2B portfolio in Q1 2026.
- Freestone Grove Partners opened 515 new positions and closed 267 in Q1 2026.
- Freestone Grove Partners's portfolio value rose 2.4% quarter-over-quarter to $14.2B.
Based on Freestone Grove Partners's 13F filing for Q1 2026, filed 15 May 2026.